DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 1.820-1.860 for the period, compared to the consensus EPS estimate of 1.980. The company issued revenue guidance of $3.8 billion-$3.8 billion, compared to the consensus revenue estimate of $3.9 billion. DENTSPLY SIRONA also updated its FY24 guidance to $1.82-$1.86 EPS.
DENTSPLY SIRONA Price Performance
XRAY stock traded down $6.72 during mid-day trading on Thursday, reaching $17.26. 29,886,019 shares of the company traded hands, compared to its average volume of 3,084,600. DENTSPLY SIRONA has a 52-week low of $17.22 and a 52-week high of $37.60. The company has a market capitalization of $3.50 billion, a P/E ratio of -20.07, a P/E/G ratio of 1.27 and a beta of 1.02. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. The company has a fifty day moving average price of $24.82 and a 200-day moving average price of $25.98.
Analyst Ratings Changes
Several research analysts have commented on the stock. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research note on Thursday, July 18th. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Wednesday. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research report on Friday, October 25th. Finally, Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a research report on Monday, July 22nd. Five equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $31.88.
Get Our Latest Stock Report on DENTSPLY SIRONA
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
